Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Mehr lesenProfessor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
| Arztbesuch | preis auf anfrage |
| Entfernung von Hirntumoren | $20000 - $40000 |
| Arztbesuch | preis auf anfrage |
| Entfernung von Hirntumoren | $20000 - $40000 |
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Oncologist-mammologist
Treatment of mastopathy, which causes pain and swelling of the mammary gland
Treatment of large breast cysts without surgical aspiration
Treatment of duct ectasia (dilation) and galactorrhea
Obtaining a smear from the secretion of the mammary gland
Treatment of adenosis and other precancerous diseases of the mammary gland
Biopsy of pathological formations on the skin of the mammary gland
Hormonal treatment for breast cancer
Treatment of precancerous diseases of other organs
Cancer Treatment
Symptomatic treatment of cancer patients
Mistletoe therapy and cancer treatment with high doses of vitamin C.
Elimination of complications and side effects of chemotherapy and radiation therapy
Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)
Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.
Mehr lesenOncologist-mammologist
Treatment of mastopathy, which causes pain and swelling of the mammary gland
Treatment of large breast cysts without surgical aspiration
Treatment of duct ectasia (dilation) and galactorrhea
Obtaining a smear from the secretion of the mammary gland
Treatment of adenosis and other precancerous diseases of the mammary gland
Biopsy of pathological formations on the skin of the mammary gland
Hormonal treatment for breast cancer
Treatment of precancerous diseases of other organs
Cancer Treatment
Symptomatic treatment of cancer patients
Mistletoe therapy and cancer treatment with high doses of vitamin C.
Elimination of complications and side effects of chemotherapy and radiation therapy
Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)
Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.
Experience
2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.
2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.
2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid
Qualification
2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain
2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.
1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.
2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.
1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"
1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"
1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"
1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.
Teaching :
2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.
2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.
2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.
2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.
2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.
2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.
1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).
Publications
2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.
2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047
2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.
2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.
2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.
Presentations
2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.
2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018
2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.
2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia
2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.
Communities it belongs to:
-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)
-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"
-SSRI, International Society for Stereotactic Radiosurgery
- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).
Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.
Mehr lesenExperience
2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.
2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.
2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid
Qualification
2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain
2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.
1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.
2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.
1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"
1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"
1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"
1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.
Teaching :
2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.
2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.
2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.
2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.
2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.
2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.
1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).
Publications
2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.
2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047
2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.
2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.
2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.
Presentations
2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.
2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018
2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.
2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia
2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.
Communities it belongs to:
-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)
-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"
-SSRI, International Society for Stereotactic Radiosurgery
- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).
Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.
Dr Reema Arora has been a national and international trainer in BOTOX® and Fillers for the past 18 years. She has worked with Allergan India Pvt Ltd. as Medical Head- Facial Aesthetics and has the credit of training over 1500 Dermatologist and Plastic surgeons in the art of facial rejuvenation with injectables.
Dr. Arora has single handedly revolutionized the use of Botox and dermal fillers in India with new innovations and focus on Indian faces. She has perfected the art of using Botox, Juvederm, and Voluma amongst other injectables to rejuvenate, enhance and treat the whole face including -facial asymmetries, defining various facial features like the nose, jaw, lips and resolving excessive sweating.
Dr Reema Arora has been a national and international trainer in BOTOX® and Fillers for the past 18 years. She has worked with Allergan India Pvt Ltd. as Medical Head- Facial Aesthetics and has the credit of training over 1500 Dermatologist and Plastic surgeons in the art of facial rejuvenation with injectables.
Dr. Arora has single handedly revolutionized the use of Botox and dermal fillers in India with new innovations and focus on Indian faces. She has perfected the art of using Botox, Juvederm, and Voluma amongst other injectables to rejuvenate, enhance and treat the whole face including -facial asymmetries, defining various facial features like the nose, jaw, lips and resolving excessive sweating.
Dr. Arora made the switch to cosmetic medicine in 2006 following her passion for Aesthetics. She has been trained in Australia, Korea and Singapore with acclaimed dermatologist and plastic surgeons. Dr. Reema Arora is a medical graduate from St John’s Medical College Hospital and a postgraduate in Paediatrics.She went on to do her Masters in Aesthetic Medicine from London in 2018 and has gone on to become a brand in herself in Facial Aesthetics, continuously perfecting her well honed skills. Being India’s leading Rejuvenation expert for over 8 years, Dr. Reema Arora has always been a pioneer in Injectables. She constantly updates her techniques and extensive knowledge of the subject by attending training workshops and seminars.
Mehr lesenDr Reema Arora has been a national and international trainer in BOTOX® and Fillers for the past 18 years. She has worked with Allergan India Pvt Ltd. as Medical Head- Facial Aesthetics and has the credit of training over 1500 Dermatologist and Plastic surgeons in the art of facial rejuvenation with injectables.
Dr. Arora has single handedly revolutionized the use of Botox and dermal fillers in India with new innovations and focus on Indian faces. She has perfected the art of using Botox, Juvederm, and Voluma amongst other injectables to rejuvenate, enhance and treat the whole face including -facial asymmetries, defining various facial features like the nose, jaw, lips and resolving excessive sweating.
Dr Reema Arora has been a national and international trainer in BOTOX® and Fillers for the past 18 years. She has worked with Allergan India Pvt Ltd. as Medical Head- Facial Aesthetics and has the credit of training over 1500 Dermatologist and Plastic surgeons in the art of facial rejuvenation with injectables.
Dr. Arora has single handedly revolutionized the use of Botox and dermal fillers in India with new innovations and focus on Indian faces. She has perfected the art of using Botox, Juvederm, and Voluma amongst other injectables to rejuvenate, enhance and treat the whole face including -facial asymmetries, defining various facial features like the nose, jaw, lips and resolving excessive sweating.
Dr. Arora made the switch to cosmetic medicine in 2006 following her passion for Aesthetics. She has been trained in Australia, Korea and Singapore with acclaimed dermatologist and plastic surgeons. Dr. Reema Arora is a medical graduate from St John’s Medical College Hospital and a postgraduate in Paediatrics.She went on to do her Masters in Aesthetic Medicine from London in 2018 and has gone on to become a brand in herself in Facial Aesthetics, continuously perfecting her well honed skills. Being India’s leading Rejuvenation expert for over 8 years, Dr. Reema Arora has always been a pioneer in Injectables. She constantly updates her techniques and extensive knowledge of the subject by attending training workshops and seminars.
Professor Dr. Gökmen
General Surgeon
Professor Dr. Gökmen
General Surgeon
Dr. Aydoğan embarked on his medical career, graduating from Bornova Anadolu High School in 2004. Subsequently, he pursued his studies at Celal Bayar University Medical Faculty, earning his medical doctor degree in 2011. His professional journey began as a general practitioner at Şanlıurfa Birecik State Hospital. In 2012, he achieved a significant milestone by successfully passing the Medical Specialty Exam (TUS) and commencing his specialization in surgery at the Bozyaka General Surgery Department in Izmir. Dr. Aydoğan’s pursuit of excellence took him to Heidelberg University Hospital in Germany in 2015, one of the country’s top institutions, where he worked as a visiting doctor. During this period, his focus was on pancreatic and liver surgery, gaining valuable experience. In 2017, he earned the title of specialist in general surgery through his thesis, which evaluated the demographic characteristics and surgical effectiveness of patients undergoing Sleeve Gastrectomy (gastric sleeve surgery) for obesity. The years 2018 to 2019 saw him fulfill his mandatory service at Ardahan Göle State Hospital, further enhancing his experience and skills. In 2020, Dr. Aydoğan joined the team at Izmir Tepecik Training and Research Hospital, where he primarily performed cancer surgery, obesity surgery, and minimally invasive surgery, including laparoscopic procedures. In 2022, he reached another milestone in his career by establishing his own private practice. Here, he continues his medical journey, providing care independently and making a positive impact in the field of surgery and healthcare.
Mehr lesenDr. Aydoğan embarked on his medical career, graduating from Bornova Anadolu High School in 2004. Subsequently, he pursued his studies at Celal Bayar University Medical Faculty, earning his medical doctor degree in 2011. His professional journey began as a general practitioner at Şanlıurfa Birecik State Hospital. In 2012, he achieved a significant milestone by successfully passing the Medical Specialty Exam (TUS) and commencing his specialization in surgery at the Bozyaka General Surgery Department in Izmir. Dr. Aydoğan’s pursuit of excellence took him to Heidelberg University Hospital in Germany in 2015, one of the country’s top institutions, where he worked as a visiting doctor. During this period, his focus was on pancreatic and liver surgery, gaining valuable experience. In 2017, he earned the title of specialist in general surgery through his thesis, which evaluated the demographic characteristics and surgical effectiveness of patients undergoing Sleeve Gastrectomy (gastric sleeve surgery) for obesity. The years 2018 to 2019 saw him fulfill his mandatory service at Ardahan Göle State Hospital, further enhancing his experience and skills. In 2020, Dr. Aydoğan joined the team at Izmir Tepecik Training and Research Hospital, where he primarily performed cancer surgery, obesity surgery, and minimally invasive surgery, including laparoscopic procedures. In 2022, he reached another milestone in his career by establishing his own private practice. Here, he continues his medical journey, providing care independently and making a positive impact in the field of surgery and healthcare.